114 related articles for article (PubMed ID: 12189257)
1. Elevated cholesterol levels associated with nonresponse to fluoxetine treatment in major depressive disorder.
Sonawalla SB; Papakostas GI; Petersen TJ; Yeung AS; Smith MM; Sickinger AH; Gordon J; Israel JA; Tedlow JR; Lamon-Fava S; Fava M
Psychosomatics; 2002; 43(4):310-6. PubMed ID: 12189257
[TBL] [Abstract][Full Text] [Related]
2. Hopelessness as a predictor of non-response to fluoxetine in major depressive disorder.
Papakostas GI; Petersen T; Homberger CH; Green CH; Smith J; Alpert JE; Fava M
Ann Clin Psychiatry; 2007; 19(1):5-8. PubMed ID: 17453655
[TBL] [Abstract][Full Text] [Related]
3. Pain has a strong negative impact on the fluoxetine response in hospitalized patients with major depressive disorder.
Lin CH; Lane HY; Chen CC; Juo SH; Yen CF
Clin J Pain; 2011; 27(9):805-10. PubMed ID: 21677571
[TBL] [Abstract][Full Text] [Related]
4. Can serotonin and fluoxetine levels in plasma and platelets predict clinical response in depression?
Castrogiovanni P; Blardi P; De Lalla A; Dell'Erba A; Auteri A
Psychopharmacol Bull; 2003; 37(2):102-8. PubMed ID: 14566218
[TBL] [Abstract][Full Text] [Related]
5. Fluoxetine once every third day in the treatment of major depressive disorder.
Tural U; Onder E
Eur Arch Psychiatry Clin Neurosci; 2003 Dec; 253(6):307-12. PubMed ID: 14714120
[TBL] [Abstract][Full Text] [Related]
6. Predictors of fluoxetine remission for hospitalized patients with major depressive disorder.
Lin CH; Lane HY; Chen CC; Juo SH; Yen CF
Psychiatry Clin Neurosci; 2011 Aug; 65(5):510-7. PubMed ID: 21851460
[TBL] [Abstract][Full Text] [Related]
7. Hypothyroidism and hyperthyroidism in major depression revisited.
Fava M; Labbate LA; Abraham ME; Rosenbaum JF
J Clin Psychiatry; 1995 May; 56(5):186-92. PubMed ID: 7737957
[TBL] [Abstract][Full Text] [Related]
8. Double-blind comparison of bupropion and fluoxetine in depressed outpatients.
Feighner JP; Gardner EA; Johnston JA; Batey SR; Khayrallah MA; Ascher JA; Lineberry CG
J Clin Psychiatry; 1991 Aug; 52(8):329-35. PubMed ID: 1907963
[TBL] [Abstract][Full Text] [Related]
9. Fluoxetine versus placebo in depressed alcoholic cocaine abusers.
Cornelius JR; Salloum IM; Thase ME; Haskett RF; Daley DC; Jones-Barlock A; Upsher C; Perel JM
Psychopharmacol Bull; 1998; 34(1):117-21. PubMed ID: 9564208
[TBL] [Abstract][Full Text] [Related]
10. Predictors of an acute antidepressant response to fluoxetine and sertraline.
Flament MF; Lane RM; Zhu R; Ying Z
Int Clin Psychopharmacol; 1999 Sep; 14(5):259-75. PubMed ID: 10529069
[TBL] [Abstract][Full Text] [Related]
11. Antidepressant response and well-being in pre-, peri- and postmenopausal women with major depressive disorder treated with fluoxetine.
Cassano P; Soares CN; Cusin C; Mascarini A; Cohen LS; Fava M
Psychother Psychosom; 2005; 74(6):362-5. PubMed ID: 16244512
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of fluoxetine and doxepin in treatment of melancholia in depressed patients.
Sandor P; Baker B; Irvine J; Dorian P; McKessok D; Mendlowitz S
Depress Anxiety; 1998; 7(2):69-72. PubMed ID: 9614594
[TBL] [Abstract][Full Text] [Related]
13. Plasma free 3-methoxy-4-hydroxyphenylglycol predicts response to fluoxetine.
Ko HC; Lu RB; Shiah IS; Hwang CC
Biol Psychiatry; 1997 Apr; 41(7):774-81. PubMed ID: 9084896
[TBL] [Abstract][Full Text] [Related]
14. Fluoxetine treatment of dysthymia in the elderly.
Nobler MS; Devanand DP; Kim MK; Fitzsimons LM; Singer TM; Turret N; Sackeim HA; Roose SP
J Clin Psychiatry; 1996 Jun; 57(6):254-6. PubMed ID: 8666563
[TBL] [Abstract][Full Text] [Related]
15. Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder.
Fava M; McCall WV; Krystal A; Wessel T; Rubens R; Caron J; Amato D; Roth T
Biol Psychiatry; 2006 Jun; 59(11):1052-60. PubMed ID: 16581036
[TBL] [Abstract][Full Text] [Related]
16. A double-blind, placebo-controlled comparison of venlafaxine and fluoxetine treatment in depressed outpatients.
Nemeroff CB; Thase ME;
J Psychiatr Res; 2007; 41(3-4):351-9. PubMed ID: 16165158
[TBL] [Abstract][Full Text] [Related]
17. Problem-solving ability and comorbid personality disorders in depressed outpatients.
Harley R; Petersen T; Scalia M; Papakostas GI; Farabaugh A; Fava M
Depress Anxiety; 2006; 23(8):496-501. PubMed ID: 16845662
[TBL] [Abstract][Full Text] [Related]
18. Double-blind study of high-dose fluoxetine versus lithium or desipramine augmentation of fluoxetine in partial responders and nonresponders to fluoxetine.
Fava M; Alpert J; Nierenberg A; Lagomasino I; Sonawalla S; Tedlow J; Worthington J; Baer L; Rosenbaum JF
J Clin Psychopharmacol; 2002 Aug; 22(4):379-87. PubMed ID: 12172337
[TBL] [Abstract][Full Text] [Related]
19. Fluoxetine versus trazodone: efficacy and activating-sedating effects.
Beasley CM; Dornseif BE; Pultz JA; Bosomworth JC; Sayler ME
J Clin Psychiatry; 1991 Jul; 52(7):294-9. PubMed ID: 2071559
[TBL] [Abstract][Full Text] [Related]
20. Major depressive subtypes and treatment response.
Fava M; Uebelacker LA; Alpert JE; Nierenberg AA; Pava JA; Rosenbaum JF
Biol Psychiatry; 1997 Oct; 42(7):568-76. PubMed ID: 9376453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
